Product logins

Find logins to all Clarivate products below.

home   •  Research Reports  •  Disease Landscape and Forecast Insights
$16,500.00   |  '

Immune-Mediated Inflammatory Myopathies | Executive Insights | US | 2020

Login to access report north_east
Buy report north_east

Immune-mediated inflammatory myopathies (IMIMs) are rare disorders that encompass multiple subtypes including dermatomyositis, immune-mediated necrotizing myopathy or necrotizing autoimmune myopathy (NAM), and alpha-synthetase syndrome. While their pathogenesis is unclear, research is rapidly uncovering novel targets and disease markers. The management of these disorders is evolving as autoantibody markers are linked to patient comorbidities, as patient heterogeneity increasingly comes into focus, and as novel drugs progress through the pipeline. Potential line extensions for branded biologics are also nearing final stages of the pipeline. With an increasingly crowded pipeline and a limited number of patients and multiple treating physicians, which therapies are poised to dominate these niche markets?

QUESTIONS ANSWERED

· What is the diagnosed prevalence of dermatomyositis, of immune-mediated necrotizing myopathy, and of the alpha-synthetase syndrome?

· How are each of the subpopulations treated today?

· What are the key areas of unmet need and opportunity in the management of immune-mediated inflammatory myopathies?

· What is the potential impact of new launches and how will these therapies affect future opportunity in the different subtypes of immune-mediated inflammatory myopathies?

· What are the key drivers and limiters of the market today and in the future?

PRODUCT DESCRIPTION

Executive Insights provides indication-specific market intelligence with world-class epidemiology, keen insight into current treatment paradigms, biotherapeutic pipelines, key clinical unmet needs, and competitive landscapes, supported by primary and secondary research. This solution provides succinct insights to any biopharma function or business professional looking to quickly grasp a new indication of interest.

Buy report north_east
Login to access report north_east

Related Market Assessment Reports

Report
Gout – Current Treatment – Treatment Algorithms: Claims Data Analysis – Gout (US)
Gout, a form of inflammatory arthritis, arises due to the persistent elevation of serum uric acid (sUA) levels. The condition manifests through sudden and intense gout flares, causing significant…
north_east
Report
Scleroderma (Systemic Sclerosis) – Current Treatment – Treatment Algorithms: Claims Data Analysis – Scleroderma (Systemic Sclerosis) (US)
Scleroderma (systemic sclerosis) (SSc) is a rare progressive autoimmune disorder characterized by skin fibrosis, systemic inflammation, and vasculopathy that can manifest as Raynaud’s phenomenon…
north_east
Report
Alopecia – Current Treatment – Treatment Algorithms: Claims Data Analysis – Alopecia Areata (US)
Alopecia areata (AA) is an inflammatory autoimmune skin disease characterized by the targeting of anagen hair follicles by the host immune system, resulting in varying degrees of hair loss. Topical…
north_east
Report
Hypertrophic Cardiomyopathy – Current Treatment – Treatment Algorithms: Claims Data Analysis – Hypertrophic Cardiomyopathy (US)
HCM is a genetic heart condition characterized by thickened myocardium and left ventricular hypertrophy, often linked to sarcomere mutations. While some patients remain asymptomatic, common…
north_east
Report
Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia – Geographic Focus: China – Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia – China In-Depth (China)
The NHL therapy market in China is poised for significant growth over the next decade, driven by the introduction of novel therapies and the continued uptake and label expansion of premium-priced…
north_east

Follow us

Contact us

Sales enquiries north_east
Customer service north_east
Support north_east